Full article: Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium
Hydroxide Skip to Main Content Taylor and Francis Online homepage Taylor and Francis …

Aluminum-containing adjuvants are widely used in preventive vaccines against infectious
diseases and in preparations for allergy immunotherapy. The mechanism by which they …

Allergen-specific immunotherapy has been carried out for almost a century and remains one
of the few antigen-specific treatments for inflammatory diseases. The mechanisms by which …

Toll-like receptors (TLRs) are essential components of innate immunity and provide
defensive inflammatory responses to invading pathogens. Located within the plasma …

Aluminum-containing adjuvants are an important component of many vaccines because
they safely potentiate the immune response. The structure and properties of aluminum …

The Allergic Rhinitis and its Impact on Asthma document was first published in 2001. Since
then, new data on specific immunotherapy have appeared. This review is intended as an …

Background B‐type CpG oligodeoxynucleotides (ODN) is currently used in clinical trials
because of its prolonged half–life, which is due to its phosphorothioate backbone. A‐type …

Allergic rhinitis (AR) affects more than 20% of the population in the United Kingdom and
western Europe and represents a major cause of morbidity that includes interference with …

Aluminum-containing adjuvants are widely used in licensed human and veterinary vaccines.
However, the mechanism by which these adjuvants enhance the immune response and …

Objective New insights into mechanisms should enable strategic improvement of allergen
immunotherapy, aiming to make it safer, faster, more effective, and able to induce long-term …